Advanced search×

Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.

Martin M Wagner, Ahsan A Alam, Josef J Zimmermann, Katharina K Rauh, Angelika A Koljaja-Batzner, Ulrike U Raff, Christoph C Wanner, and Lothar L Schramm

Clin J Am Soc Nephrol 6(7):1573-9 (2011) PMID 21734083

Anemia and inflammation are prevalent in diabetic patients with chronic kidney disease (CKD). The role of endogenous erythropoietin (EPO) in the pathophysiology of anemia in chronic diseases and its relationship to clinical outcomes remain uncertain. In this cohort study, we aimed to identify factors associated with endogenous EPO levels and investigate their relation to all-cause mortality.

DOI: 10.2215/CJN.00380111
Version: za2963e q8za9 q8zb9 q8zcf q8zd0 q8ze5 q8zf9 q8zg3

Similar articles you may find interesting…

  1. Bone alkaline phosphatase and mortality in dialysis patients.
    Christiane C Drechsler, Marion M Verduijn, ...

    Clin J Am Soc Nephrol 6(7):1752-9 (2011) PMID 21597029

  2. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic sy...
    Alfred A Callahan, Pierre P Amarenco, ...

    Arch Neurol 68(10):1245-51 (2011) PMID 21670382

    The SPARCL subjects with type 2 diabetes were at higher risk for recurrent stroke and cardiovascular events. This exploratory analysis found no difference in the effect of statin treatment in reducing these events in subjects with or without type 2 diabetes or MetS. Trial Registration  clinicaltria...